Answer
Quviviq (daridorexant hydrochloride) is not recommended for patients with severe hepatic impairment.
Sources for this answer
- QUVIVIQ 50 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked